Year: 2025
Type: article
Abstract: The following highlights showcase late-breaking research presented at the European Association for the Study of the Liver (EASL) Congress 2025.Topics ranged from alanine transaminase testing as a screening tool for paediatric metabolic dysfunction-associated steatotic liver disease to the risks of moderate alcohol use in liver disease, and novel siRNA therapies for hepatitis B.
Source: EMJ Hepatology
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4411458304